DKSH and Bayer launch strategic partnership across multiple markets in Southeast Asia

DKSH Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Service...

July 10, 2025 | Thursday | News
Japan's JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M

Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...

July 10, 2025 | Thursday | News
China's CStone inks deal worth $192.5 M with Istituto Gentili to commercialise cancer drug in Europe

China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...

July 10, 2025 | Thursday | News
Health2Sync and Novo Nordisk enhance insulin administration via digital diabetes care in Korea

Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...

July 9, 2025 | Wednesday | News
Korea's Celltrion announces US launch of denosumab biosimilars for osteoporosis treatment

Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...

July 8, 2025 | Tuesday | News
Chugai and Gero ink $250 M deal to develop new therapies for age-related diseases

Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...

July 9, 2025 | Wednesday | News
BioVersys inks deal worth CHF 479 M with Japan's Shionogi to treat infectious diseases

BioVersys AG, a multi-asset, clinical stage biopharmaceutical company based in Switzerland, focusing on research an...

July 4, 2025 | Friday | News
China's Brii Biosciences announces new agreement to address global antimicrobial resistance threats

Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across disea...

July 4, 2025 | Friday | News
Gero’s ProtoBind‑Diff redefines drug discovery by designing molecules from sequence alone

BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...

July 2, 2025 | Wednesday | Opinion
Why AI-Enabled ‘Dirty Drugs’ are Future for Longevity Medicine

What if a key part of the solution to Asia’s looming demographic crisis lies in embracing something we in the phar...

July 1, 2025 | Tuesday | Opinion
“The burden on medical and long-term care systems due to ageing is expected to intensify in Japan”

What major initiatives are lined up for Asahi's healthcare business in 2025 and beyond? Are you planning any major inves...

July 1, 2025 | Tuesday | Opinion
Medical Advances Soar With APAC’s Clinical Trial Growth

It’s universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports conf...

July 1, 2025 | Tuesday | Analysis
Australia's Neurizon develops liquid formulation of NUZ-001 for treatment of Amyotrophic Lateral Sclerosis

Neurizon Therapeutics, a clinical-stage biotech company based in Australia, has announced the development of a new oral ...

June 30, 2025 | Monday | News
China approves world's first dual GCG/GLP-1 receptor agonist for weight loss

Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazduti...

June 30, 2025 | Monday | News
SK Biosciences partners with PhnyX Lab to streamline drug discovery research using AI

South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation PhnyX Lab in ...

June 27, 2025 | Friday | News
Bayer extends partnership with Tsinghua University to accelerate pharma research in China

Bayer and Tsinghua University (THU) have announced the signing of the sixth phase of the collaboration agreement, aiming...

June 27, 2025 | Friday | News
EVA Pharma and Porton Advanced Solutions to expand CAR T-cell therapy access in Middle East and Africa

EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East ...

June 26, 2025 | Thursday | News
Syngene Charts Global Biologics Growth with India at Its Core

  Syngene’s Global Biologics Strategy: Flexibility, Innovation, and India’s Growing Talent Pipeline S...

June 25, 2025 | Wednesday | Analysis